Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Antioxidant drugs protect b-cells from oxidative stress caused by hyperglycemia. Nonetheless small concentrations of reactive oxygen species support the insulin secretory response to glucose. b-cells contain superoxide dismutase but not catalase or glutathione peroxidase. This suggests b-cells may lack a peroxidase defense so that during physiologic situations low levels of H2O2 are developed to support insulin gene expression/secretion. My studies will examine regulation of glucose-induced insulin secretion by intracellular H2O2 and the possible adverse consequences on b-cell function of excess H2O2 catabolism by antioxidant drugs

EF 2008-09

Résumé
Clinical reports of elevated levels of oxidative stress markers in patients with type 2 diabetes mellitus (T2DM) are numerous. This is particularly relevant for the islet, which is among those tissues with the lowest levels of intrinsic antioxidant defenses. Beta cell-specific localization and expression of such antioxidant proteins remain unknown. Chronic elevations in glucose leads to the production of reactive oxygen species (ROS) accumulation, and over time cause chronic adverse effects (glucose toxicity) leading to b-cell decompensation, which is a hallmark of T2DM. Decreases in b-cell function found in chronic glucotoxic states include decreases in insulin gene expression, insulin content, and glucose-induced insulin secretion (GSIS). Our laboratory has shown that these defects in b-cell function can be prevented with administration of pharmacological antioxidants or enhancing intrinsic islet antioxidant defenses both in vitro and in vivo. However, since the islet contains enzymes that produce H2O2, and very low levels of some enzymes that catabolize H2O2, it is likely that small amounts of H2O2 contribute to b-cell function. Very few studies exist, that have examined b-cell-specific localization and expression of antioxidant proteins, especially pertaining to those proteins which are able to catabolize H2O2. Recent findings have implicated ROS as a coupler between b-cell glucose metabolism and insulin secretion, which is consistent with my hypothesis that pancreatic b-cells lack peroxidase enzymes such as catalase and glutathione peroxidase because H2O2 generation is required for normal b-cell function. The purpose of this work is to localize and characterize the regulation of b-cell-specific peroxidase antioxidant proteins and to elucidate the role of ROS, namely H2O2 in promoting insulin production and/or secretion which will increase our understanding of the implications of this unusual antioxidant profile of the b-cell.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Washington, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
179946
Name
Kiraly Michael A
Region
Washington
Country
United States of America
Orgtype
Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Fellowships - Post-PhD
Projecttitle
Antioxidant drugs protect b-cells from oxidative stress caused by hyperglycemia. Nonetheless small concentrations of reactive oxygen species support the insulin secretory response to glucose. b-cells contain superoxide dismutase but not catalase or glutathione peroxidase. This suggests b-cells may lack a peroxidase defense so that during physiologic situations low levels of H2O2 are developed to support insulin gene expression/secretion. My studies will examine regulation of glucose-induced insulin secretion by intracellular H2O2 and the possible adverse consequences on b-cell function of excess H2O2 catabolism by antioxidant drugs
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Antioxidant Proteins; Beta-Cell; Diabetes; Free Radicals/Reactive Oxygen Species; Hyperglycemia; In Vivo; Islet; Overexpression; Oxidative Stress; Regulation
Abstract
Clinical reports of elevated levels of oxidative stress markers in patients with type 2 diabetes mellitus (T2DM) are numerous. This is particularly relevant for the islet, which is among those tissues with the lowest levels of intrinsic antioxidant defenses. Beta cell-specific localization and expression of such antioxidant proteins remain unknown. Chronic elevations in glucose leads to the production of reactive oxygen species (ROS) accumulation, and over time cause chronic adverse effects (glucose toxicity) leading to b-cell decompensation, which is a hallmark of T2DM. Decreases in b-cell function found in chronic glucotoxic states include decreases in insulin gene expression, insulin content, and glucose-induced insulin secretion (GSIS). Our laboratory has shown that these defects in b-cell function can be prevented with administration of pharmacological antioxidants or enhancing intrinsic islet antioxidant defenses both in vitro and in vivo. However, since the islet contains enzymes that produce H2O2, and very low levels of some enzymes that catabolize H2O2, it is likely that small amounts of H2O2 contribute to b-cell function. Very few studies exist, that have examined b-cell-specific localization and expression of antioxidant proteins, especially pertaining to those proteins which are able to catabolize H2O2. Recent findings have implicated ROS as a coupler between b-cell glucose metabolism and insulin secretion, which is consistent with my hypothesis that pancreatic b-cells lack peroxidase enzymes such as catalase and glutathione peroxidase because H2O2 generation is required for normal b-cell function. The purpose of this work is to localize and characterize the regulation of b-cell-specific peroxidase antioxidant proteins and to elucidate the role of ROS, namely H2O2 in promoting insulin production and/or secretion which will increase our understanding of the implications of this unusual antioxidant profile of the b-cell.
Competitiondate
200902
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kiraly, Michael A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~